Patents by Inventor Andrew WURMSER

Andrew WURMSER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BCMA-BINDING ANTIBODIES AND USES THEREOF
    Publication number: 20220324991
    Abstract: Antibody species that bind B-Cell Maturation Antigen (BCMA) are provided as well as methods of depleting BCMA-expressing cells in a patient in need thereof, comprising administering a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof. Methods of treating B cell-related disorders associated with BCMA expression in a patient in need thereof are provided, comprising administering to the patient a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof.
    Type: Application
    Filed: June 17, 2022
    Publication date: October 13, 2022
    Inventors: Mahan Abbasian, Henry Chan, Kandasamy Hariharan, Jeonghoon Sun, Andrew Wurmser
  • BCMA-binding antibodies and uses thereof
    Patent number: 11401336
    Abstract: Antibody species that bind B-Cell Maturation Antigen (BCMA) are provided as well as methods of depleting BCMA-expressing cells in a patient in need thereof, comprising administering a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof. Methods of treating B cell-related disorders associated with BCMA expression in a patient in need thereof are provided, comprising administering to the patient a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: August 2, 2022
    Assignee: CELGENE CORPORATION
    Inventors: Mahan Abbasian, Henry Chan, Kandasamy Hariharan, Jeonghoon Sun, Andrew Wurmser
  • BCMA-BINDING ANTIBODIES AND USES THEREOF
    Publication number: 20200399386
    Abstract: Antibody species that bind B-Cell Maturation Antigen (BCMA) are provided as well as methods of depleting BCMA-expressing cells in a patient in need thereof, comprising administering a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof. Methods of treating B cell-related disorders associated with BCMA expression in a patient in need thereof are provided, comprising administering to the patient a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof.
    Type: Application
    Filed: February 20, 2019
    Publication date: December 24, 2020
    Inventors: Mahan Abbasian, Henry Chan, Kandasamy Hariharan, Jeonghoon Sun, Andrew Wurmser
  • Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof
    Patent number: 9623028
    Abstract: Provided herein are methods for treating or preventing a cancer, in particular solid tumors and hematological cancers, comprising administering to a subject in need thereof an effective amount of a compound of formula (I):
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: April 18, 2017
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Dan Zhu, John Boylan, Shuichan Xu, Jennifer Riggs, Tao Shi, Andrew Wurmser, David Mikolon, Gordafaried Deyanat-Yazdi
  • METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF
    Publication number: 20160008365
    Abstract: Provided herein are methods for treating or preventing a cancer, in particular solid tumors and hematological cancers, comprising administering to a subject in need thereof an effective amount of a compound of formula (I):
    Type: Application
    Filed: July 13, 2015
    Publication date: January 14, 2016
    Inventors: Dan ZHU, John BOYLAN, Shuichan XU, Jennifer RIGGS, Tao SHI, Andrew WURMSER, David MIKOLON, Gordafaried DEYANAT-YAZDI